- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT00624234
Neurobiology and Treatment of Reading Disability in NF-1
Neurobiology and Treatment of Reading Disability in Neurofibromatosis Type 1 (NF-1)
Study Overview
Status
Conditions
Intervention / Treatment
Detailed Description
The most common concern of parents of children with neurofibromatosis type 1 (NF-1) is learning disabilities (LD). Approximately one half of all children with NF-1 have LD-the most debilitating and common of which are reading disabilities.
The purpose of this study is to determine if children with NF-1 who have reading disabilities respond the same way-both behaviorally and neurobiologically-to specialized treatment programs known to improve the decoding deficits in children with idiopathic reading disabilities. The trial will also determine which intervention is best for particular learner profiles. The overall purpose of this research is to gain a deeper understanding of the characteristics and treatment of reading disabilities in NF-1.
In the trial, researchers will compare children with NF-1 who show weaknesses in reading to children with reading disabilities of no known cause (idiopathic) using two different interventions and behavioral and neurobiological measures. Both interventions focus on teaching sound-symbol relationships, but vary in terms of relative emphasis on verbal versus visual methods of teaching.
Scientists hope findings from the trial will advance knowledge about the best therapies for LD in children with NF-1. And, by further refining how children with NF-1 who have reading disabilities are similar (or different) to children with idiopathic reading disabilities, the researchers may be able to learn if reading interventions that address areas other than decoding will also benefit children with NF-1. Also, by understanding the similarities and/or differences in the neuropsychological and neurobiological profiles of children with NF-1 who have reading disabilities, and those without, scientists will be able to refine the cognitive phenotype and neurobiological characteristics of NF-1, which will further understanding of central nervous system abnormalities in NF-1.
Study Type
Enrollment (Actual)
Phase
- Not Applicable
Contacts and Locations
Study Locations
-
-
Tennessee
-
Nashville, Tennessee, United States, 37232-2310
- Vanderbilt University, Vanderbilt University Institute of Imaging Science
-
-
Participation Criteria
Eligibility Criteria
Ages Eligible for Study
Accepts Healthy Volunteers
Description
Inclusion Criteria:
This study will be open to all individuals, ages 8 to 17 years, who meet eligibility criteria regardless of race, gender, or socioeconomic status.
- The Reading Disabilities group (including those with NF-1) is defined by scoring equal to or less than the 25th percentile on measures of basic word reading skills.
- The Control group (including those with NF1) is defined by scoring equal to or above the 40th percentile on the average of the Letter Word Identification and Word Attack subtests from the WJ-III.
Exclusion Criteria:
Any child, regardless of which group he/she is recruited for, will be excluded if he/she meets any of the following criteria (determined during phone screening, medical review, and during testing):
- is in foster care;
- previous diagnosis of mental retardation;
- known uncorrectable visual impairment;
- history of known neurological disorder (e.g., epilepsy, spina bifida, cerebral palsy, traumatic brain injury);
- documented hearing impairment greater than 25 dB loss in either ear;
- medical contraindication to MRI procedures, if participating in MRI (including exposure to metal and pregnancy);
- individuals known to have an IQ below 70;
- history or presence of a pervasive developmental disorder;
- during the DICA-IV parents indicate the presence of any severe psychiatric diagnoses or pervasive developmental disorder.
Study Plan
How is the study designed?
Design Details
- Primary Purpose: Treatment
- Allocation: Randomized
- Interventional Model: Parallel Assignment
- Masking: Single
Arms and Interventions
Participant Group / Arm |
Intervention / Treatment |
|---|---|
|
Experimental: NF-Tutoring Program 1
Tutoring Program I
|
Tutoring Program I is a structured multi-sensory program that is designed to gradually present the range of sounds and letters with focus on accuracy of phonological concepts and application of those concepts in phrases and sentences.
The instruction uses a sequenced defined lesson plan with accuracy and automaticity criteria for skill progression.
A range of manipulative and kinesthetic activities is outlined to maintain learner engagement in the intensive intervention design.
|
|
Experimental: NF-Tutoring Program 2
Tutoring Program II
|
Tutoring Program II is designed to teach visual and speech elements of reading separately at first, and then bring them together for maximum efficiency.
The program uses the idea of teaching concepts about the structure of words.
For example, students transfer the rules they have learned about one vowel or structure to another without specific instructions on the new one.
Tutoring Program II incorporates pictures and activities to help remember strategies for increasing basic reading skills.
Speed drills are also used for development of decoding automaticity.
|
|
No Intervention: Typically Developing Readers
Control group
|
|
|
Experimental: IRD-Tutoring Program 1
Tutoring Program I
|
Tutoring Program I is a structured multi-sensory program that is designed to gradually present the range of sounds and letters with focus on accuracy of phonological concepts and application of those concepts in phrases and sentences.
The instruction uses a sequenced defined lesson plan with accuracy and automaticity criteria for skill progression.
A range of manipulative and kinesthetic activities is outlined to maintain learner engagement in the intensive intervention design.
|
|
Experimental: IRD-Tutoring Program 2
Tutoring Program II
|
Tutoring Program II is designed to teach visual and speech elements of reading separately at first, and then bring them together for maximum efficiency.
The program uses the idea of teaching concepts about the structure of words.
For example, students transfer the rules they have learned about one vowel or structure to another without specific instructions on the new one.
Tutoring Program II incorporates pictures and activities to help remember strategies for increasing basic reading skills.
Speed drills are also used for development of decoding automaticity.
|
|
No Intervention: Waitlist Control
Intervention Control Group (RD)
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
Change From Baseline in WJ-III Basic Reading Normative Update (Woodcock Johnson Psychoeducational Battery - 3rd Edition; WJ-III NU) Standard Score at 15 Hours
Time Frame: 0 and 15 hours
|
This metric measures change in reading abilities, including word recognition and decoding, as assessed by standard educational assessments (Woodcock Johnson Psychoeducational Battery - 3rd Edition Normative Update; WJ-III NU).
The scores are reported as change in age-normed standard scores (a change of 15 standard score points would represent a change of 1 standard deviation in the general population).The Basic Reading score is a normed composite of the WJ-III subtests Letter-Word Identification and Word Attack, representing word-level reading skill.
|
0 and 15 hours
|
Secondary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
Neuroimaging Data
Time Frame: Collected before and after intervention
|
Neuroimaging data consists of functional MRI and structural MRI measures.
|
Collected before and after intervention
|
Collaborators and Investigators
Sponsor
Investigators
- Principal Investigator: Laurie E. Cutting, Ph.D., Vanderbilt University Special Education Department
- Principal Investigator: Martha Bridge Denckla, M.D., Kennedy Krieger Institute, Johns Hopkins University, Johns Hopkins University School of Medicine
- Principal Investigator: Sheryl L. Rimrodt, M.D., Vanderbilt University Pediatrics Department
- Principal Investigator: John Gore, Ph.D., Vanderbilt University
Publications and helpful links
Helpful Links
Study record dates
Study Major Dates
Study Start (Actual)
Primary Completion (Actual)
Study Completion (Actual)
Study Registration Dates
First Submitted
First Submitted That Met QC Criteria
First Posted (Estimated)
Study Record Updates
Last Update Posted (Actual)
Last Update Submitted That Met QC Criteria
Last Verified
More Information
Terms related to this study
Keywords
Additional Relevant MeSH Terms
- Specific Learning Disorder
- Neurologic Manifestations
- Nervous System Diseases
- Mental Disorders
- Neoplasms
- Neuromuscular Diseases
- Genetic Diseases, Inborn
- Peripheral Nervous System Diseases
- Neoplasms by Histologic Type
- Neurobehavioral Manifestations
- Neurodegenerative Diseases
- Neurodevelopmental Disorders
- Neoplasms, Nerve Tissue
- Nervous System Neoplasms
- Heredodegenerative Disorders, Nervous System
- Nerve Sheath Neoplasms
- Neoplastic Syndromes, Hereditary
- Neurocutaneous Syndromes
- Peripheral Nervous System Neoplasms
- Communication Disorders
- Language Disorders
- Learning Disabilities
- Neurofibromatoses
- Neurofibromatosis 1
- Neurofibroma
- Dyslexia
Other Study ID Numbers
- R01NS049096 (U.S. NIH Grant/Contract)
- NF1-R01
Plan for Individual participant data (IPD)
Plan to Share Individual Participant Data (IPD)?
IPD Plan Description
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Neurofibromatosis Type 1
-
Pasithea Therapeutics Corp.Novotech (Australia) Pty LimitedRecruitingNeurofibroma, Plexiform | Neurofibroma Plexiform | Neurofibromatosis Type 1 (NF1) | Neurofibromatosis Type 1 (NF1)-Related Plexiform Neurofibromas (PNs) | NF1 MutationAustralia, United States, South Korea
-
University of UtahUniversity of British Columbia; Children's Hospital Medical Center, Cincinnati and other collaboratorsTerminatedNeurofibromatosis Type 1 (NF1)United States, Canada
-
University of Alabama at BirminghamCompletedNeurofibromatosis Type 1 and Growing or Symptomatic, Inoperable PNUnited States
-
Novartis PharmaceuticalsTerminatedPlexiform Neurofibroma Associated With Neurofibromatosis Type 1Israel
-
SpringWorks Therapeutics, Inc., a healthcare company...Active, not recruitingPlexiform Neurofibroma | Neurofibromatosis Type 1 (NF1)United States
-
AstraZenecaCompletedHealthy Participants | Neurofibromatosis Type 1 (NF1)-Related Plexiform Neurofibromas (PNs)United States
-
National Cancer Institute (NCI)Active, not recruitingLow Grade Glioma | Recurrent Visual Pathway Glioma | Refractory Visual Pathway Glioma | Recurrent Childhood Pilocytic Astrocytoma | Recurrent Neurofibromatosis Type 1 | Refractory Neurofibromatosis Type 1United States
-
National Cancer Institute (NCI)CompletedPlexiform Neurofibroma | Neurofibromatosis Type IUnited States
-
Massachusetts General HospitalJohns Hopkins UniversitySuspendedNeurofibromatosis 1 (NF1) | Neurofibromatosis Type IUnited States
-
NYU Langone HealthNational Institute of Neurological Disorders and Stroke (NINDS)Not yet recruitingNeurofibromatosis Type 1
Clinical Trials on Tutoring Program I
-
McGill University Health Centre/Research Institute...CompletedLearning DisabilitiesCanada
-
San Diego State UniversitySwiss Tropical & Public Health Institute; Centre Suisse de Recherches Scientifiques...Not yet recruitingAcademic Performance | Educational Attainment | Secondary School Entry and Completion | School Attendance | Education AdvancementCôte d’Ivoire
-
Education University of Hong KongCompleted
-
University of Erlangen-NürnbergGerman Federal Ministry of Education and ResearchCompleted
-
The Hospital for Sick ChildrenChildren's Hospital of Eastern OntarioCompletedAttention Deficit Disorder With Hyperactivity | Learning DisordersCanada
-
Penn State UniversityNational Institute of Mental Health (NIMH)CompletedAttention Deficit Disorder With Hyperactivity
-
Tokat Gaziosmanpasa UniversityRecruitingEducational ProblemsTurkey
-
Vanderbilt UniversityEunice Kennedy Shriver National Institute of Child Health and Human Development...Recruiting
-
Washington University School of MedicineNational Heart, Lung, and Blood Institute (NHLBI); Medical College of Wisconsin and other collaboratorsCompletedSickle Cell DiseaseUnited States
-
The University of Hong KongCompleted